Allergan buys second fatty liver-disease company

Sept 20 (Reuters) - Allergan Inc on Tuesday said it

had paid $50 million for Akarna Therapeutics Ltd, a privately

held company developing treatments for a incurable fatty liver

disease called NASH.

Read more